• 1
    Johnson LF, Mossong J, Dorrington RE et al. Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies. PLoS Med 2013; 10: e1001418.
  • 2
    Cohen MS, Chen YQ, McCauley M et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365: 493505.
  • 3
    Tanser F, Barnighausen T, Grapsa E, Zaidi J, Newell ML. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science 2013; 339: 966971.
  • 4
    World Health Organization. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for A Public Health Approach. Geneva, WHO, 2013.
  • 5
    Gardner EM, McLees MP, Steiner JF, del Rio C, Burman WJ. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis 2011; 52: 793800.
  • 6
    May M, Gompels M, Delpech V et al. Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study. BMJ 2011; 343: d6016.
  • 7
    Hall HI, Holtgrave DR, Maulsby C. HIV transmission rates from persons living with HIV who are aware and unaware of their infection. AIDS 2012; 26: 893896.
  • 8
    Centers for Diseases Control and Prevention (CDC). Vital signs: HIV prevention through care and treatment-United States. MMWR Morb Mortal Wkly Rep 2011; 60: 16181623.
  • 9
    Hamers FF, Phillips AN. Diagnosed and undiagnosed HIV-infected populations in Europe. HIV Med 2008; 9 (Suppl 2): 612.
  • 10
    Kranzer K, Govindasamy D, Ford N, Johnston V, Lawn SD. Quantifying and addressing losses along the continuum of care for people living with HIV infection in sub-Saharan Africa: a systematic review. J Int AIDS Soc 2012; 15: 17383.
  • 11
    Chikovani I, Goguadze K, Ranade S, Wertlieb M, Rukhadze N, Gotsadze G. Prevalence of HIV among injection drug users in Georgia. J Int AIDS Soc 2011; 14: 9.
  • 12
    Tsereteli N, Chikovani I, Chkhaidze N, Goguadze K, Shengelia N, Rukhadze N. HIV testing uptake among female sex workers and men who have sex with men in Tbilisi, Georgia. HIV Med 2013; 14 (Suppl 3): 2932.
  • 13
    Lazarus JV, Hoekstra M, Raben D, Delpech V, Coenen T, Lundgren JD. The case for indicator condition-guided HIV screening. HIV Med 2013; 14: 445448.
  • 14
    Helleberg M, Engsig FN, Kronborg G et al. Retention in a public healthcare system with free access to treatment. AIDS 2012; 26: 741748.
  • 15
    Mugglin C, Estill J, Wandeler G et al. Loss to programme between HIV diagnosis and initiation of antiretroviral therapy in sub-Saharan Africa: systematic review and meta-analysis. Trop Med Int Health 2012; 17: 15091520.
  • 16
    Rosen S, Fox MP. Retention in HIV care between testing and treatment in sub-Saharan Africa: a systematic review. PLoS Med 2011; 8: e1001056.
  • 17
    Westergaard RP, Hess T, Astemborski J, Mehta SH, Kirk GD. Longitudinal changes in engagement in care and viral suppression for HIV-infected injection drug users. AIDS 2013; 27: 25592566.
  • 18
    Westergaard RP, Ambrose BK, Mehta SH, Kirk GD. Provider and clinic-level correlates of deferring antiretroviral therapy for people who inject drugs: a survey of North American HIV providers. J Int AIDS Soc 2012; 15: 10.
  • 19
    Clouse K, Pettifor A, Maskew M et al. Initiating antiretroviral therapy when presenting with higher CD4 cell counts results in reduced loss to follow-up in a resource-limited setting. AIDS 2013; 27: 645650.
  • 20
    World Health Organization. Framework for Metrics to Support Eeffective Treatment As Prevention. Geneva, WHO, 2012.